Fig. 1

Chemical structures of (A) Theaflagallin (B) Epigallocatechin 3-O-cinnamate (C), Epicatechin gallate, (D) control drug Plixorafenib and (E) Co-crystalized ligand (2-{4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridin-4-yl)-1H-pyrazol-1-yl}ethanol) by using ChemDraw, version 22.0 (https://revvitysignals.com/products/research/chemdraw).